Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression (original) (raw)
- Original Paper
- Published: 20 October 1999
Cell Death & Differentiation volume 6, pages 1002–1011 (1999)Cite this article
- 688 Accesses
- 55 Citations
- 3 Altmetric
- Metrics details
Abstract
IL-15 shares many biological properties with IL-2, a cytokine whose administration to HIV-infected individuals has been effective in enhancing depleted CD4 T lymphocyte numbers. The present study examined whether exogenous IL-15 could protect lymphocytes of HIV-infected individuals from spontaneous apoptosis, associated with growth factor deprivation, and CD95-induced apoptosis, which is believed to play a major role in T lymphocyte loss and HIV pathogenesis. Although IL-15, like IL-2, failed to inhibit CD95-induced lymphocyte apoptosis in vitro, IL-15 was found to act as a potent survival factor in the prevention of spontaneous apoptosis. The greater enhancement of lymphocyte survival, promoted by IL-15 as compared with IL-2 when used at an equivalent concentration, was associated with higher up-regulation of bcl-2 expression. In addition, IL-15 was more potent than IL-2 in stimulating lymphocyte proliferation. Despite the strong ability of IL-15 to promote both lymphocyte survival and proliferation, the increases in representation and total numbers of viable cells induced by IL-15 were not higher than those induced by IL-2. This appears to be associated with the greater ability of IL-15 to activate lymphocytes and increase their apoptosis-susceptibility. Therefore, lymphocyte loss occurring by growth factor deprivation in HIV infection may be potentially prevented by IL-15, although its benefits for survival need to be closely assessed against its ability to augment lymphocyte activation.
Similar content being viewed by others
Author information
Authors and Affiliations
- Unité d'Oncologie Virale and URA CNRS 1930, Departement SIDA et Retrovirus Institut Pasteur, 28 Rue du Dr. Roux, Paris, 75724, Cedex 15, France
Honami Naora & Marie-Lise Gougeon
Authors
- Honami Naora
- Marie-Lise Gougeon
Corresponding author
Correspondence toMarie-Lise Gougeon.
Additional information
Edited by R. Knight
Rights and permissions
About this article
Cite this article
Naora, H., Gougeon, ML. Interleukin-15 is a potent survival factor in the prevention of spontaneous but not CD95-induced apoptosis in CD4 and CD8 T lymphocytes of HIV-infected individuals. Correlation with its ability to increase BCL-2 expression.Cell Death Differ 6, 1002–1011 (1999). https://doi.org/10.1038/sj.cdd.4400575
- Received: 05 March 1999
- Revised: 17 June 1999
- Accepted: 10 August 1999
- Published: 20 October 1999
- Issue date: 01 October 1999
- DOI: https://doi.org/10.1038/sj.cdd.4400575
Keywords
This article is cited by
HIV-1 viral genes and mitochondrial apoptosis
- Devon J. Shedlock
- Daniel Hwang
- David B. Weiner
Apoptosis (2008)
Apoptosis in SIV infection
- B Hurtrel
- F Petit
- J Estaquier
Cell Death & Differentiation (2005)
Apoptosis as an HIV strategy to escape immune attack
- Marie-Lise Gougeon
Nature Reviews Immunology (2003)
- Marie-Lise Gougeon
Apoptosis and reduced influenza A virus specific CD8+ T cells in aging mice
- Y Zhang
- Y Wang
- I N Mbawuike
Cell Death & Differentiation (2002)
Biochemical mechanisms of HIV induced T cell apoptosis
- N Selliah
- T H Finkel
Cell Death & Differentiation (2001)